United Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. 

CEO
Martine A. Rothblatt
CEOMartine A. Rothblatt
Employees
1,400
Employees1,400
Headquarters
Silver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded
1996
Founded1996
Employees
1,400
Employees1,400

UTHR Key Statistics

Market cap
23.21B
Market cap23.21B
Price-Earnings ratio
17.16
Price-Earnings ratio17.16
Dividend yield
Dividend yield
Average volume
624.70K
Average volume624.70K
High today
$530.50
High today$530.50
Low today
$474.49
Low today$474.49
Open price
$496.72
Open price$496.72
Volume
1.16M
Volume1.16M
52 Week high
$537.19
52 Week high$537.19
52 Week low
$266.98
52 Week low$266.98

Stock Snapshot

The current United Therapeutics(UTHR) stock price is $530.50, with a market capitalization of 23.21B. The stock trades at a price-to-earnings (P/E) ratio of 17.16.

As of 2026-03-09, United Therapeutics(UTHR) stock has fluctuated between $474.49 and $530.50. The current price stands at $530.50, placing the stock +11.8% above today's low and 0.0% off the high.

United Therapeutics(UTHR) shares are trading with a volume of 1.16M, against a daily average of 624.7K.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $537.19 and a 52-week low of $266.98.

In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $537.19 and a 52-week low of $266.98.

UTHR News

TipRanks 1h
United Therapeutics Launches Major Accelerated Share Repurchase Program

United Therapeutics ( (UTHR) ) just unveiled an announcement. United Therapeutics’ board on March 8, 2026 authorized a new stock repurchase program of up to $2...

Nasdaq 11h
United Therapeutics Authorized $2 Bln Buy Back

(RTTNews) - United Therapeutics Corporation (UTHR), a medical company, Monday announced that it authorized a new share repurchase program of up to $2 billion ov...

United Therapeutics Authorized $2 Bln Buy Back
TipRanks 12h
United Therapeutics announces $2B share repurchase program, $1.5B ASR

United Therapeutics (UTHR) announced that the company’s board of directors has authorized a new stock repurchase program of up to $2B over the next year. In add...

Analyst ratings

75%

of 16 ratings
Buy
75%
Hold
25%
Sell
0%

More UTHR News

TipRanks 4d
Top United Therapeutics Insiders Quietly Cash Out in Major Stock Moves

New insider activity at United Therapeutics ( (UTHR) ) has taken place on March 5, 2026. United Therapeutics has seen notable insider selling activity, with tw...

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.